BHST stock Statistics — Bioharvest Sciences INC. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2025-12-31 · filed common shares: 22.66M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.33%
Short ratioDays to cover, as published by FINRA: 1.95
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 60.70%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 44.30%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Avg volume (3 months)

Gross marginFY Dec 25: 59.34%
Operating marginFY Dec 25: -16.16%
Net margin: —
EBITDA marginFY Dec 25: -11.45%
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: -83.17%
Return on assetsNet income (FY Dec 25) ÷ average total assets: -30.65%

Cash & equivalentsas of Dec 25: $23.02M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: $1.55M
Debt / equityas of Dec 25: 6.11%
Current ratioas of Dec 25: 3.97
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Dec 25: 3.25
Operating cash flowFY Dec 25: -$7.22M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: -$9.58M
TTM revenue / diluted share: —